NCT00537901View on ClinicalTrials.gov

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Colonic NeoplasmsRectal Neoplasms
Interventions
RADIATION

First-Line Bevacizumab and Chemotherapy

Chemotherapy

DRUG

Bevacizumab

Chemotherapy

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT00537901 - First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study | Biotech Hunter | Biotech Hunter